blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0667150

EP0667150 - Venlafaxine and its analogues for inducing cognition enhancement [Right-click to bookmark this link]
Former [1995/33]Venlamafaxine and its analogues for inducing cognition enhancement
[2002/08]
StatusNo opposition filed within time limit
Status updated on  17.10.2003
Database last updated on 11.09.2024
Most recent event   Tooltip17.10.2003No opposition filed within time limitpublished on 03.12.2003  [2003/49]
Applicant(s)For all designated states
Wyeth
Five Giralda Farms
Madison, NJ 07940-0874 / US
[N/P]
Former [2002/25]For all designated states
Wyeth
Five Giralda Farms
Madison, New Jersey 07940-0874 / US
Former [1995/33]For all designated states
AMERICAN HOME PRODUCTS CORPORATION
Five Giralda Farms
Madison, New Jersey 07940-0874 / US
Inventor(s)01 / Husbands, George Edward Morris
258 Dayleview Road
Berwyn, Pennsylvania 19312 / US
02 / Abou-Gharbia, Magid Abdel-Megid
6 James Hayward Road
Glen Mills, Pennsylvania 19342 / US
03 / Moyer, John Allen
6274 Ingham Road
New Hope, Pennsylvania 18938 / US
04 / Muth, Eric Anthony
10 Sugan Close
New Hope, Pennsylvania 18938 / US
[1995/33]
Representative(s)Connelly, Michael John, et al
C/o Patent Department Wyeth Laboratories Huntercombe Lane South Taplow
Maidenhead Berkshire SL6 0PH / GB
[N/P]
Former [1995/33]Connelly, Michael John, et al
c/o Patent Department Wyeth Laboratories Huntercombe Lane South Taplow
Maidenhead Berkshire SL6 0PH / GB
Application number, filing date95300612.931.01.1995
[1995/33]
Priority number, dateUS1994019541714.02.1994         Original published format: US 195417
[1995/33]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP0667150
Date:16.08.1995
Language:EN
[1995/33]
Type: B1 Patent specification 
No.:EP0667150
Date:11.12.2002
Language:EN
[2002/50]
Search report(s)(Supplementary) European search report - dispatched on:EP21.06.1995
ClassificationIPC:A61K31/135, A61K31/275, A61P25/28
[2002/08]
CPC:
A61K31/135 (EP); A61P25/28 (EP)
Former IPC [1995/33]A61K31/135, A61K31/275
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   NL,   PT,   SE [1995/33]
TitleGerman:Venlafaxin und seine Analoga zum Herbeiführen einer Verbesserung der kognitiven Funktionen[1995/33]
English:Venlafaxine and its analogues for inducing cognition enhancement[2002/08]
French:Venlafaxine et ses analogues pour induire une amélioration des fonctions cognitives[1995/33]
Former [1995/33]Venlamafaxine and its analogues for inducing cognition enhancement
Examination procedure01.02.1996Examination requested  [1996/14]
02.07.1999Despatch of a communication from the examining division (Time limit: M04)
04.10.1999Reply to a communication from the examining division
25.01.2000Despatch of a communication from the examining division (Time limit: M06)
17.07.2000Reply to a communication from the examining division
28.09.2000Despatch of a communication from the examining division (Time limit: M06)
22.03.2001Reply to a communication from the examining division
11.01.2002Despatch of communication of intention to grant (Approval: Yes)
11.07.2002Communication of intention to grant the patent
08.10.2002Fee for grant paid
08.10.2002Fee for publishing/printing paid
Divisional application(s)EP02014620.5  / EP1245228
Opposition(s)12.09.2003No opposition filed within time limit [2003/49]
Fees paidRenewal fee
18.11.1996Renewal fee patent year 03
17.11.1997Renewal fee patent year 04
18.11.1998Renewal fee patent year 05
27.12.1999Renewal fee patent year 06
05.01.2001Renewal fee patent year 07
10.01.2002Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[DA]US4535186  (HUSBANDS G E MORRIS [US], et al) [DA] 1-9 * column W *;
 [PX]CA2126305  (AMERICAN HOME PROD [US])[PX] 1-9;
 [E]EP0639374  (AMERICAN HOME PROD [US]) [E] 1-9 * the whole document *
 [X]  - Saletu B et al, "Pharmacodynamics of venlafaxine evaluated by EEG brain mapping, psychometry and psychophysiology.", BR J CLIN PHARMACOL (ENGLAND), JUN 1992, VOL. 33, NO. 6, PAGE(S) 589-601, [X] 1-9 * the whole document *
 [PX]  - Cunningham LA et al, "A comparison of venlafaxine, trazodone, and placebo in major depression.", J CLIN PSYCHOPHARMACOL (UNITED STATES), APR 1994, VOL. 14, NO. 2, PAGE(S) 99-106, [PX] 1-9 * the whole document *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.